Target intelligence / Profile preview

PTCHD1 antisense RNA (head to head) (PTCHD1-AS)

Target
PTCHD1-AS
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

PTCHD1 antisense RNA (head to head), abbreviated as PTCHD1-AS, is a long non-coding RNA (lncRNA) located on the X chromosome, oriented head-to-head with the PTCHD1 gene[4][5][6][7]. It does not code for protein. Genetic deletions involving PTCHD1-AS have been strongly linked to susceptibility for autism spectrum disorder (ASD) in males, particularly with deficits in social behavior and repetitive actions without intellectual disability or ADHD[1][3]. Experimental studies in human neurons and knockout mice indicate its critical role in regulating synaptic function and gene expression pathways involved in neurodevelopment, especially in GABAergic regions like the striatum[1][3]. While also known by aliases such as DDX53-AS1 and PHEX-AS1, PTCHD1-AS is not a conventional therapeutic target (such as a receptor or enzyme) and there are no drugs targeting it directly. Its precise biological function is under investigation, though it may offer insights into the molecular basis of ASD and related neurological conditions[1][3][4][5].

Other names
PTCHD1AS1PTCHD1AS2DDX53-AS1DDX53 antisense RNA 1 (non-protein coding)PHEX antisense RNA 1 (non-protein coding)PHEX-AS1
02

Biological functions

Regulation of synaptic functionModulation of gene expressionNeurodevelopmental regulation
03

Disease associations

Autism spectrum disorderNeurodevelopmental disorderHypophosphatemic rickets (associated, but causality largely for protein-coding neighbors)

Beyond the preview

Go deeper on PTCHD1 antisense RNA (head to head) (PTCHD1-AS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PTCHD1 antisense RNA (head to head) (PTCHD1-AS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call